Anteris Technologies Global (NASDAQ:AVR) Shares Down 5.8% – Here’s What Happened

Anteris Technologies Global Corp. (NASDAQ:AVR)’s stock price dropped 5.8% during trading on Tuesday . The company traded as low as $8.79 and last traded at $9.06. Approximately 231,645 shares were traded during mid-day trading, a decline of 79% from the average daily volume of 1,125,993 shares. The stock had previously closed at $9.62.

Analyst Upgrades and Downgrades

Several research firms have issued reports on AVR. Wells Fargo & Company assumed coverage on shares of Anteris Technologies Global in a research report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price target for the company. Barclays boosted their target price on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Cantor Fitzgerald restated an “overweight” rating and set a $15.00 target price on shares of Anteris Technologies Global in a report on Friday, March 27th. Finally, Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Anteris Technologies Global has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.

Anteris Technologies Global Stock Performance

The firm has a market cap of $905.26 million, a PE ratio of -4.17 and a beta of 1.32. The company’s 50-day simple moving average is $6.23 and its two-hundred day simple moving average is $5.54.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The firm had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. During the same quarter in the previous year, the firm posted ($0.61) EPS. On average, analysts expect that Anteris Technologies Global Corp. will post -1.14 EPS for the current year.

Institutional Investors Weigh In On Anteris Technologies Global

Institutional investors and hedge funds have recently bought and sold shares of the business. Russell Investments Group Ltd. grew its position in shares of Anteris Technologies Global by 76.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock worth $29,000 after buying an additional 2,841 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Anteris Technologies Global during the first quarter valued at approximately $32,000. BNP Paribas Financial Markets raised its holdings in shares of Anteris Technologies Global by 83.3% during the third quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock valued at $43,000 after acquiring an additional 4,302 shares in the last quarter. Bank of America Corp DE lifted its stake in Anteris Technologies Global by 35.7% in the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after acquiring an additional 2,798 shares during the period. Finally, Duncan Williams Asset Management LLC purchased a new position in Anteris Technologies Global during the 4th quarter valued at $54,000.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.